Literature DB >> 24416566

Commissioning and Acceptance Testing of the existing linear accelerator upgraded to volumetric modulated arc therapy.

Ekambaram Varadharajan1, Velayudham Ramasubramanian2.   

Abstract

AIM: The RapidArc commissioning and Acceptance Testing program will test and ensure accuracy in DMLC position, precise dose-rate control during gantry rotation and accurate control of gantry speed.
BACKGROUND: Recently, we have upgraded our linear accelerator capable of performing IMRT which was functional from 2007 with image guided RapidArc facility. The installation of VMAT in the existing linear accelerator is a tedious process which requires many quality assurance procedures before the proper commissioning of the facility and these procedures are discussed in this study.
MATERIALS AND METHODS: Output of the machine at different dose rates was measured to verify its consistency at different dose rates. Monitor and chamber linearity at different dose rates were checked. DMLC QA comprising of MLC transmission factor measurement and dosimetric leaf gap measurements were performed using 0.13 cm(3) and 0.65 cm(3) Farmer type ionization chamber, dose 1 dosimeter, and IAEA 30 cm × 30 cm × 30 cm water phantom. Picket fence test, garden fence test, tests to check leaf positioning accuracy due to carriage movement, calibration of the leaves, leaf speed stability effects due to the acceleration and deceleration of leaves, accuracy and calibration of leaves in producing complex fields, effects of interleaf friction, etc. were verified using EDR2 therapy films, Vidar scanner, Omnipro accept software, amorphous silicon based electronic portal imaging device and EPIQA software.(1-8.)
RESULTS: All the DMLC related quality assurance tests were performed and evaluated by film dosimetry, portal dosimetry and EPIQA.(7.)
CONCLUSION: Results confirmed that the linear accelerator is capable of performing accurate VMAT.

Entities:  

Keywords:  Dynamic MLC; EDR2 film; EPIQA; Film dosimetry; Portal dosimetry; Volumetric modulated arc therapy

Year:  2013        PMID: 24416566      PMCID: PMC3863227          DOI: 10.1016/j.rpor.2013.07.008

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  10 in total

1.  Commissioning of volumetric modulated arc therapy (VMAT).

Authors:  James L Bedford; Alan P Warrington
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-01       Impact factor: 7.038

2.  Exit fluence analysis using portal dosimetry in volumetric modulated arc therapy.

Authors:  Prabakar Sukumar; Sriram Padmanaban; Dhanabalan Rajasekaran; Muniyappan Kannan; Vivekanandan Nagarajan
Journal:  Rep Pract Oncol Radiother       Date:  2012-07-15

3.  A study on dosimetric properties of electronic portal imaging device and its use as a quality assurance tool in Volumetric Modulated Arc Therapy.

Authors:  Prabakar Sukumar; Sriram Padmanaban; Prakash Jeevanandam; S A Syam Kumar; Vivekanandan Nagarajan
Journal:  Rep Pract Oncol Radiother       Date:  2011-08-26

4.  Commissioning and quality assurance of RapidArc radiotherapy delivery system.

Authors:  C Clifton Ling; Pengpeng Zhang; Yves Archambault; Jiri Bocanek; Grace Tang; Thomas Losasso
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

5.  Dosimetric verification of RapidArc treatment delivery.

Authors:  Stine Korreman; Joakim Medin; Flemming Kjaer-Kristoffersen
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

Review 6.  Intensity-modulated arc therapy: principles, technologies and clinical implementation.

Authors:  Cedric X Yu; Grace Tang
Journal:  Phys Med Biol       Date:  2011-02-04       Impact factor: 3.609

7.  Clinical significance of multi-leaf collimator positional errors for volumetric modulated arc therapy.

Authors:  Mike Oliver; Isabelle Gagne; Karl Bush; Sergei Zavgorodni; Will Ansbacher; Wayne Beckham
Journal:  Radiother Oncol       Date:  2010-12       Impact factor: 6.280

8.  EPID in vivo dosimetry in RapidArc technique.

Authors:  Krzysztof Slosarek; Marta Szlag; Barbara Bekman; Aleksandra Grzadziel
Journal:  Rep Pract Oncol Radiother       Date:  2010-02-20

9.  Quality assurance methodology for Varian RapidArc treatment plans.

Authors:  Ileana Iftimia; Eileen T Cirino; Li Xiong; Herbert W Mower
Journal:  J Appl Clin Med Phys       Date:  2010-09-01       Impact factor: 2.102

10.  The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy.

Authors:  Giorgia Nicolini; Eugenio Vanetti; Alessandro Clivio; Antonella Fogliata; Stine Korreman; Jiri Bocanek; Luca Cozzi
Journal:  Radiat Oncol       Date:  2008-09-09       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.